Julia Hütter

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

Lisa M. Dunkle, Karen L. Kotloff, Cynthia L. Gay et al. · New England Journal of Medicine · 2021 · 445 citations · Full text

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 334 citations · Full text

Vaccination, Vaccine Development, Nhp 13-19 +9

The Classical Lancefield Antigen of Group A Streptococcus Is a Virulence Determinant with Implications for Vaccine Design

Nina M. van Sorge, Jason N. Cole, Kirsten Kuipers et al. · Cell Host & Microbe · 2014 · 154 citations · Full text

Vaccination, Reverse Vaccinology, Vaccine Development +11

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Youyi Fong, Yunda Huang, David Benkeser et al. · Nature Communications · 2023 · 96 citations · Full text

A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa

Linda‐Gail Bekker, One Dintwe, Andrew Fioré-Gartland et al. · EClinicalMedicine · 2020 · 73 citations · Full text